The Journal of Endocrinology, Metabolism and Diabetes of South Africa (JEMDSA) is the official journal of SEMDSA (Society for Endocrinology, Metabolism and Diabetes of SA), DESSA (Diabetes Education Society of SA), NOFSA (National Osteoporosis Foundation of SA), SASOM (SA Society of Obesity and Metabolism), LASSA (Lipid and Atherosclerosis Society of SA) and PAEDS-SA (The Paediatric and Adolescent Endocrine and Diabetes Society of SA).

Through stringent peer review, the journal also aims to make a regional contribution to the international knowledge base of endocrinology, metabolism and diabetes and hopes to also offer other African countries the opportunity to make a world-class African contribution.

Readership comprises of the members of the various societies, namely general physicians, endocrinologists, diabetologists, diabetes nurse educators, lipidologists, beriatricians, paediatricians, gynaecologists (specialising in osteoporosis and infertility) and general practitioners with a special interest in endocrinology, metabolism and diabetes.

Obesity in patients – the importance of broaching the topic and the benefits of pharmacotherapy as an adjunct

The World Health Organization has found that more than 28% of adults in South Africa are obese, the highest obesity rate amongst sub-Saharan African countries. Obesity is widely acknowledged to be associated with many health risks and diseases including type 2 diabetes, heart disease, stroke, hypertension, joint pain and certain cancers. Dr Daksha Jivan, an endocrinologist in the Division of Endocrinology at Charlotte Maxeke Johannesburg Academic Hospital, says that healthcare practitioners need to introduce the topic of obesity with their patients and make them aware of their BMI, tell them about the potential risks and problems associated with obesity, screen them for complications early and make them aware that there is medication available to assist them. “I can’t stress enough how important it is for HCPs to broach the topic with their patients,” she says.3

Achieving a sustainable Festive Season

Keeping the holidays eco-friendly may seem like a daunting and perhaps, at times, even a somewhat impossible task. However, there are entirely manageable strategies to ensure that you can celebrate the Festive Season fully while also achieving sustainability. The Festive Season is often a time where waste increases. Many products that are not eco-friendly and/or biodegradable are used in large supply. The increased use of plastics, electricity, water and cleaning products lead to a real threat on sustainability – putting your health, your loved ones’ health, and the environment at risk.

Notification of permanent price reduction for Gemzar 200 mg and Gemzar 1 g

Eli Lilly (SA) (PTY) Limited is pleased to announce a 36.6% permanent price reduction for Gemzar 200 mg and for Gemzar 1 g effective 29 November 2019. Gemzar has been in South Africa for 24 years for the management of NSCLC, breast cancer, pancreatic cancer, recurrent epithelial ovarian cancer, and transitional cell bladder cancer.

SmartCRUTCH is the safest, most comfortable, technically advanced crutch ever designed and manufactured – Now available in South Africa

SmartCrutch’s CEO, Colin Albertyn, is the designer, founder and manufacturer of this new innovative SmartCrutch. SmartCrutch has impressed many internationally with its new unique crutch, the SmartCrutch is engineered with robust and durable materials and is available online and through appointed distributors in 15 countries.

Liquid replacement in a lolly

We’ve all been there – when we have a sick child with a fever, diarrhoea or vomiting and as parents, one of our main concerns is how best to replace all those lost fluids. What makes it worse is that often the last thing a sick child feels like is drinking anything. Fortunately, Créche Guard, South Africa’s number 1 children’s multivitamin and mineral supplement, has launched a new product to assist with fluid and nutrient replenishment in children, in a lolly format.

Wildcard SSL